BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1801465)

  • 1. [Functional state of thrombocytes in Yersinia infection].
    Kravchenko AV; Lomazova KhD; Poliakova AM; Buriachkovskaia LI; Novoselova EIu; Maleev VV
    Vestn Akad Med Nauk SSSR; 1991; (10):9-13. PubMed ID: 1801465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The clinical manifestations and differential diagnosis of Yersinia hepatitis and viral hepatitis A and B].
    Shakhgil'dian DI; Iushchuk ND; Karetkina GN; Braginskiĭ DM; Doroshenko NV; Sergeeva NA
    Ter Arkh; 1993; 65(11):19-22. PubMed ID: 8108790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intestinal dysbacteriosis in yersiniosis patients and the possibility of its correction with biopreparations].
    Kuznetsov VF; Iushchuk ND; Iurko LP; Nabokova NIu
    Ter Arkh; 1994; 66(11):17-8. PubMed ID: 7900004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The intensity of cell receptor catabolism in intestinal yersiniosis and pseudotuberculosis].
    Kudrina NV; Besednova NN
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (3):65-7. PubMed ID: 10851995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroepidemiologic study on the occurrence of antibodies against Yersinia enterocolitica and Yersinia pseudotuberculosis in urban and rural population of the Lublin region (eastern Poland).
    Stojek NM
    Ann Agric Environ Med; 1999; 6(1):57-61. PubMed ID: 10384217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Yersinia pseudotuberculosis and Yersinia enterocolitica].
    Mollaret HH
    Rev Rhum Mal Osteoartic; 1983 Nov; 50(11):713-7. PubMed ID: 6364313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The serodiagnosis of human infections with Yersinia enterocolitica and Yersinia pseudotuberculosis.
    Chart H; Cheasty T
    FEMS Immunol Med Microbiol; 2006 Aug; 47(3):391-7. PubMed ID: 16872375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Meningitis in yersiniosis].
    Domashenko ON; Bondarev LS
    Lik Sprava; 1993; (10-12):100-2. PubMed ID: 8030289
    [No Abstract]   [Full Text] [Related]  

  • 9. [The mononuclear syndrome in yersiniosis and pseudotuberculosis].
    Bondarev LS; Tseneva GIa; Domashenko ON; Rastuntsev LP; Lugovaia IuV
    Lik Sprava; 1994; (9-12):154-6. PubMed ID: 7604559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection.
    Marcus AJ; Broekman MJ; Drosopoulos JH; Olson KE; Islam N; Pinsky DJ; Levi R
    Semin Thromb Hemost; 2005 Apr; 31(2):234-46. PubMed ID: 15852226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Humoral response to selected antigens of Yersinia enterocolitica and Yersinia pseudotuberculosis in the course of yersiniosis in humans. IV. Specificity of antigens].
    Rastawicki W
    Med Dosw Mikrobiol; 2008; 60(1):27-37. PubMed ID: 18634341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neutrophil damage test in Far Eastern scarlet-like fever (human pseudotuberculosis)].
    Timchenko NF; Dzadzieva MF; Malyĭ VP; Matiiash VV
    Lab Delo; 1982; (9):559-61. PubMed ID: 6183527
    [No Abstract]   [Full Text] [Related]  

  • 13. [The clinico-allergic indices of yersiniosis patients].
    Rashidova RA; Babakhodzhaev SN; Mukhamedov IB
    Ter Arkh; 1991; 63(11):33-5. PubMed ID: 1810058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of thrombocytes in blood coagulation disorders in infectious pathology].
    Maleev VV; Poliakova AM; Astrina OS; Lomazova KD
    Vestn Akad Med Nauk SSSR; 1991; (10):4-8. PubMed ID: 1801461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic value of a novel nutrient medium for isolation and cultivation of pathogens causing enteric yersiniosis and pseudotuberculosis].
    Saiapina LV; Anisimova TI; Sergeeva GM; Kasina IV; Shvedun GP; Khramov MV
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (6):15-8. PubMed ID: 11210625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sweet's syndrome associated with Yersinia enterocolitica infection.
    Elsner P; Hartmann AA; Lechner W
    Dermatologica; 1986; 173(2):85-9. PubMed ID: 3792603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Humoral response to selected antigens of Yersinia enterocolitica and Yersinia pseudotuberculosis in the course of yersiniosis in humans. I. Occurrence of antibodies to Yersinia lipopolisacharydes and Yop proteins by ELISA].
    Rastawicki W
    Med Dosw Mikrobiol; 2006; 58(4):303-19. PubMed ID: 17642308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental infection of mice with Yersinia strains bearing or not bearing the virulence-associated plasmid.
    Bauab TM; Falcão DP
    Contrib Microbiol Immunol; 1991; 12():144-55. PubMed ID: 1935082
    [No Abstract]   [Full Text] [Related]  

  • 19. Antithrombotic drugs in vascular medicine: a historical perspective.
    Schrör K
    Semin Vasc Med; 2003 May; 3(2):97-105. PubMed ID: 15199472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modeling of pseudotuberculosis infection].
    Polotskiĭ IuE; Tseneva GIa; Efremov VE; Kleganov VK
    Tr Inst Im Pastera; 1983; 60():91-103. PubMed ID: 6367149
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.